Kasper Mølgaard

Science👨🏼‍🔬 Diving🤿 and Football⚽️ not necessarily in that order.

[Kasper Mølgaard @kasperMoelgaard]

@AnfieldRd96 Joe Gómez would be the dream!

[Luis Álvarez-Vallina @Alvarez_Vallina]

Happy to share our paper in @ScienceTM with Engineered BCMA-specific STAb-T cells in myeloma. Thanks to all collaborators in @CNIOStopCancer, @Hospital12deOct, @CarrerasIJC (@clarabueno_74 leading force) and all the group members https://t.co/h3dqQMeMWQ

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

🔬Postdoc Research Position in Cancer Immunotherapy
Info https://t.co/vzna28BmJo

Seeking motivated scientist with expertise in cell biology, immunology, or cancer genomics
Apply by Jan 7th, 2024. PI:@DoniaMarco

#Immunotherapy #ResearchJobs #postdoc

[Kasper Mølgaard @kasperMoelgaard]

@BossLFCgoals @RedmenFamilydk og lige det sidste også 😜

[Kasper Mølgaard @kasperMoelgaard]

@BossLFCgoals @RedmenFamilydk

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy https://t.co/CaS02CZCxW @AriannaDraghi @DoniaMarco

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

🔬 Postdoc Research Position in Cancer Immunotherapy 🇩🇰
Info 👉https://t.co/LbueOG2JSW

Seeking motivated scientist with expertise in cell bio, immunology, or cancer genomics
Apply by Oct 1, 2023.
PI: @DoniaMarco

#Immunotherapy #ResearchJobs #postdoc

[Luis Álvarez-Vallina @Alvarez_Vallina]

Terapia STAb-T para cáncer hematológico desarrollada integramente en el @hospital12Oct. Gran trabajo de Belén Blanco, @AnaisJReinoso con el apoyo de @UAI_imas12 @Itemas @madrimasd. Actualmente en desarrollo clínico (ensayo Fase I Primero en Humanos) con el apoyo del @SaludISCIII

[cryoEM Papers @cryoEM_Papers]

RNA origami scaffolds facilitate cryo-EM characterization of a Broccoli–Pepper aptamer FRET pair https://t.co/Xoy6XjUmy0

[Kasper Mølgaard @kasperMoelgaard]

Huge congratulations 🎊

[Rasmus O. Bak @rasmus_o_bak]

Really excited to see the results of a fruitful collaboration with Eynav Klechevsky's team at Washington University published in Science showing the role of CD5 on dendritic cells for priming T cells to engage in effective antitumor immunity. https://t.co/HIIKglFGaC

[Kasper Mølgaard @kasperMoelgaard]

💪🏼

[CED_SFD @CED_SFD]

Meet Marina Fernandez, R&D Scientist in Thermo-Fisher Scientific ⚗️🧫🔬
She had the chance to "meet science" at a young age in school and look how far she has come!
Thank you so much Marina for your words and Thanks to Ivan R. Cuevas for video editing
#WIS #STEM #R&D #research

[TrimerbodyPharma @TrimerbodyPh]

Proud to announce PERSEO, co-founded by IISCIII, CDTI and Leadartis. PERSEO will provide the basis for the patient selection of LEAD-452 clinical development, a tumor targeted costimulatory immunotherapy based on the proprietary Trimerbody platform for the treatment of cancer.

[Kasper Mølgaard @kasperMoelgaard]

Very cool. Congratulations on the paper @nstrsampedro and team! 🎊📄

[RNA nanotechnology papers @RNAnanopapers]

An RNA Paranemic Crossover Triangle as A 3D Module for Cotranscriptional Nanoassembly https://t.co/g3dtgbyMGp

[Kasper Mølgaard @kasperMoelgaard]

@orangefeeling Josh Herring! https://t.co/7my0lws6BA

[Kasper Mølgaard @kasperMoelgaard]

@CCITdk @CAChamberlain_ Huge congratulations to both. Well deserved!

[Rasmus O. Bak @rasmus_o_bak]

Postdoc position available in my lab at Aarhus University, Denmark. The project is funded by an ERC Starting grant and focuses on hematopoietic stem cell biology and CRISPR/Cas9 transcriptional engineering. Deadline Aug. 22. https://t.co/FejkM0MWCm

[Kasper Mølgaard @kasperMoelgaard]

We are seeking an #InVivo scientist to join our #UnikumTx research team in #Aarhus. Be part of a young #biotech company focusing on cell #therapies for #cancer and #autoimmune diseases. #pDC @BioCPH @AarhusUni

[Kasper Mølgaard @kasperMoelgaard]

Impressive work. Congratulations!

[Alessio D. Nahmad @alessionahmad]

Happy to share the second study of my PhD, on engineering B cells in-vivo, out now in @NatureBiotech
🧵👇
https://t.co/DQMoJYBTxo

[UChicagoCancerCenter @UCCancerCenter]

The Kline lab published a paper in @ImmunityCP that found a new mechanism that shows how dendritic cells prime T cells to attack cancer cells https://t.co/G9HVXl0xvA